Figure 3.
Kaplan-Meier event rates for CV death or heart failure hospitalization by high risk or low risk status and randomized treatment. High risk status was defined as both Klotho concentration in Q1–3 and FGF-23 concentration in Q4. All other combinations were considered low risk.